125 related articles for article (PubMed ID: 29653642)
1. Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles.
Navar AM; Pencina MJ; Mulder H; Elias P; Peterson ED
Am Heart J; 2018 Apr; 198():18-24. PubMed ID: 29653642
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
[TBL] [Abstract][Full Text] [Related]
3. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.
Navar AM; Wang TY; Li S; Mi X; Li Z; Robinson JG; Virani SS; Peterson ED
Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e006548. PubMed ID: 33435730
[TBL] [Abstract][Full Text] [Related]
4. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
[TBL] [Abstract][Full Text] [Related]
5. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
6. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.
Tran JN; Kao TC; Caglar T; Stockl KM; Spertus JA; Lew HC; Solow BK; Chan PS
J Manag Care Spec Pharm; 2016 Aug; 22(8):901-8. PubMed ID: 27459652
[TBL] [Abstract][Full Text] [Related]
7. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
Fan W; Philip S; Granowitz C; Toth PP; Wong ND
Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
[TBL] [Abstract][Full Text] [Related]
8. Determining Percentiles of Atherosclerotic Cardiovascular Risk According to Sex and Age in a Healthy Brazilian Population.
Cesena FY; Kashiwagi NM; Minanni CA; Santos RD
Arq Bras Cardiol; 2023 Jun; 120(6):e20220552. PubMed ID: 37403871
[TBL] [Abstract][Full Text] [Related]
9. Estimated Atherosclerotic Cardiovascular Disease Risk Score: An Automated Decision Aid for Statin Therapy.
Sampson M; Wolska A; Amar M; Ueda M; Dunbar R; Soffer D; Remaley AT
Clin Chem; 2022 Oct; 68(10):1302-1310. PubMed ID: 35900196
[TBL] [Abstract][Full Text] [Related]
10. Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study.
Engeda JC; Lhachimi SK; Rosamond WD; Lund JL; Keyserling TC; Safford MM; Colantonio LD; Muntner P; Avery CL
PLoS Med; 2020 Aug; 17(8):e1003280. PubMed ID: 32845900
[TBL] [Abstract][Full Text] [Related]
11. Percentiles of predicted 10-year cardiovascular disease risk by sex and age in Brazil and their association with estimated risk of long-term atherosclerotic events.
Cesena FY; Generoso G; Santos IS; Duncan BB; Ribeiro ALP; Brant LC; Mill JG; Pereira AC; Bittencourt MS; Santos RD; Lotufo PA; Benseñor IM
Prev Med; 2023 Dec; 177():107755. PubMed ID: 37931661
[TBL] [Abstract][Full Text] [Related]
12. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
Medina-Inojosa JR; Somers VK; Garcia M; Thomas RJ; Allison T; Chaudry R; Wood-Wentz CM; Bailey KR; Mulvagh SL; Lopez-Jimenez F
J Am Coll Cardiol; 2023 Oct; 82(15):1499-1508. PubMed ID: 37793746
[TBL] [Abstract][Full Text] [Related]
13. Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.
Wong ND; Zhao Y; Xiang P; Coll B; López JAG
Am J Cardiol; 2020 Dec; 137():7-11. PubMed ID: 32991855
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
Patel KK; Taksler GB; Hu B; Rothberg MB
Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660
[TBL] [Abstract][Full Text] [Related]
15. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS
Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004
[TBL] [Abstract][Full Text] [Related]
16. The new pooled cohort equations risk calculator.
Preiss D; Kristensen SL
Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
[TBL] [Abstract][Full Text] [Related]
17. Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis.
Wong ND; Zhao Y; Quek RGW; Blumenthal RS; Budoff MJ; Cushman M; Garg P; Sandfort V; Tsai M; Lopez JAG
J Clin Lipidol; 2017; 11(5):1223-1233. PubMed ID: 28754224
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
[TBL] [Abstract][Full Text] [Related]
19. Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old.
Javaid A; Dardari ZA; Mitchell JD; Whelton SP; Dzaye O; Lima JAC; Lloyd-Jones DM; Budoff M; Nasir K; Berman DS; Rumberger J; Miedema MD; Villines TC; Blaha MJ
J Am Coll Cardiol; 2022 May; 79(19):1873-1886. PubMed ID: 35550683
[TBL] [Abstract][Full Text] [Related]
20. Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017-2020.
Chobufo MD; Regner SR; Zeb I; Lacoste JL; Virani SS; Balla S
Eur J Prev Cardiol; 2022 Oct; 29(14):1830-1838. PubMed ID: 35653373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
